Studies Evaluating Visual Outcomes After Brachytherapy in Uveal Melanoma-Strengths and Limitations of Current Investigations

JAMA Ophthalmol. 2020 Feb 1;138(2):146-147. doi: 10.1001/jamaophthalmol.2019.5122.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bevacizumab
  • Brachytherapy* / adverse effects
  • Humans
  • Melanoma* / radiotherapy
  • Uveal Melanoma
  • Uveal Neoplasms* / radiotherapy

Substances

  • Bevacizumab